AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site A4G
Virus Human respiratory syncytial virus
Mutation level Amino acid Level
Gene/protein/region type G
Gene ID 1494474
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade B
Sample Human
Variants -
Viral reference sequence JX198143.1
Drug/antibody/vaccine -
Transmissibility hinder
Transmission mechanism Our in vitro studies show that altering the G/F ratio with A4G mutation significantly decreased virus replication relative to that of the wild-type virus either without or with the 2stop mutation both in vitro and in primary infection in mice
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Attachment glycoprotein
Uniprot protein ID P03423
Protein length 298 amino acids
Protein description G protein is another target for neutralizing antibodies and it is a type II integral membrane protein composed of 298AA and weights ~ 90 kDa. It is vastly glycosylated and it is expressed in secreted and membrane-anchored forms called Gs and Gm, respectively. Gs is linked to neutralization inhibition, while Gm is related to viral attachment. This hostvirus membrane attachment is mediated by heparin sulfate proteoglycans receptor interaction. The antigenic variation is situated in the mucin domain of G protein at both C- and N- terminal ends. N- and O-glycosylation enables the protein to mature and enhances immune escape mechanisms. Other feature includes a central conserved region (CX3C motif) which is responsible for CX3CR1 binding to diminish inflammatory cytokines release.

Literature information:


Pubmed ID 33115881
Clinical information No
Disease -
Published year 2021
Journal Journal of Virology
Title A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion
Author Stacey Human,Anne L. Hotard,Christina A. Rostad,Sujin Lee,Louise McCormick
Evidence For the first virus, we changed the fourth position in the G gene end from an A to a G (A4G) to generate rA2-K-Line19F-A4G (termed rA4G henceforth).